openPR Logo
Press release

Challenges facing new biobanks, strategies for cost recovery and sustainability

03-26-2012 04:01 AM CET | Health & Medicine

Press release from: SMi Group

Challenges facing new biobanks, strategies for cost recovery

Access to samples is paramount to scientific research. Biological samples such as DNA, RNA, proteins, cells and tissues are collected from donors, processed and stored centrally for later use in experiments conducted by academia and industry alike. This has given rise to the concept of Biobanking. In 2009 the market for biobanking products and services was estimated to be worth $8B and is expected to reach $45B by 2025. UK and European biobanks are enjoying rapid growth and there is now greater impetus being put on data sharing, interoperability and harmonisation of biobanks worldwide.

SMi’s 2nd annual Biobanking event will reflect the significant change driving current development in bio sample management. With great impetus being put on data sharing, interoperability and harmonisation of biobanks, it will explain how single centre research facilities are evolving into research infrastructures. There will also be efforts to associate value to existing biological resources and coverage of important issues experienced by those who donate, manage and expend biobank samples.

Why attend this event?
• Explore challenges facing new biobanks, strategies for cost recovery and sustainability
• Discover sample requirements of researchers in drug discovery
• Communicate with solution providers who provide technological innovations for managing biobanks
• Examine quality control and quality assurance practices
• Determine how to improve your infrastructure and better network with the biobanking community
• Discuss obstacles to people donating tissue for biomedical research

For more information visit http://www.smi-online.co.uk/bio-banking-event27.asp
Alternatively contact Fateja Begum on tel: +44 (0) 20 7827 6184 or Email: fbegum@smi-online.co.uk

The SMi Group is a world leader in business to business information. With nearly two decades in the business, thousands of senior executives from blue chip companies have already benefitted from SMi’s highly targeted conferences, workshops and publications. For more information visit www.smi-online.co.uk

SMi Group Ltd
2nd Floor South, Harling House 47-51 Great Suffolk Street,
London, SE1 0BS

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Challenges facing new biobanks, strategies for cost recovery and sustainability here

News-ID: 215496 • Views:

More Releases from SMi Group

Exclusive Speaker Interview with AOBiome ahead of the 22nd Pain Therapeutics Conference
Exclusive Speaker Interview with AOBiome ahead of the 22nd Pain Therapeutics Con …
SMi Reports: Exclusive speaker interview with Todd Krueger at AOBiome released for the Pain Therapeutics Conference The pain therapeutics industry has grown at an exponential rate in recent years. The 22nd Annual Pain Therapeutics conference will cover the leading advances in pain therapeutics, exploring late development clinical trials, novel treatments for chronic conditions, technology collaboration treatments, using VR and Medical Devices that carry out non-invasive nerve stimulation. Industry leaders will uncover the
Exclusive Speaker Interview with Ester Lovsin Barle ahead of the 6th Annual Highly Potent Active Pharmaceutical Ingredients Conference.
Exclusive Speaker Interview with Ester Lovsin Barle ahead of the 6th Annual High …
Now in its 6th year, the Highly Potent Active Pharmaceutical Ingredients conference offers you peer-to-peer networking with industry experts including heads and directors of EHS, Occupational Hygiene, Quality Assurance and more. Taking place on 9th and 10th May in London, UK. With a key focus on expanding your community and exploring the latest developments in the industry at this two-day event, including key regulatory updates, and leading case studies from leading
FDA Keynote Speaker at SMi's 5th Annual Pharmaceutical Microbiology East Coast Conference in Boston, USA
FDA Keynote Speaker at SMi's 5th Annual Pharmaceutical Microbiology East Coast C …
SMi Group Reports: Keynote FDA speaker Dr. John Arigo, to present at the 4th Annual Pharmaceutical Microbiology East Coast, taking place in just 3 weeks' time on April 27th and 28th, 2022. With just three weeks remaining until the highly anticipated conference, SMi Group are delighted to announce a key FDA Speaker joining the 5th Annual Pharmaceutical Microbiology East Coast Conference. This event will take place on April 27th and
Group Captain (ret'd) Robert Daisley invites you to attend Air Mission Planning …
SMi Group reports: Chairman Group Captain (ret'd) Robert Daisley of the Air Mission Planning and Support Conference cordially invites experts to join the conference in London, UK in one week. With only one week remaining, SMi Group is delighted to publish an invitation letter for SMi's 13th Annual Air Mission Planning & Support Conference, taking place on the 6th and 7th April 2022 in London, UK from the conference chairman. The

All 5 Releases


More Releases for Biobanking

Global Biobanking Services & Biobanking Software Market Size, Share, Growth, Tre …
The Biobanking Services Market has witnessed substantial growth in recent years, driven by increasing investments in research and development activities across the healthcare and life sciences sectors. Biobanks play a crucial role in collecting, storing, and managing biological samples, such as blood, tissues, and cells, along with associated clinical and genetic data. This market's size is expected to expand significantly in the coming years due to rising demand for personalized
Biobanking Market - Strength in Diversity, Defying Disease: Biobanking Fuelling …
Newark, New Castle, USA: The "Biobanking Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Biobanking Market: https://www.growthplusreports.com/report/biobanking-market/7617 This latest report researches the industry structure, sales, revenue, price and
Mexico Biobanking Market Analysis to 2027
Biobanking Market: Overview Transparency Market Research (TMR) has published a new report on the biobanking market for the forecast period of 2019-2027. According to the report, the global biobanking market was valued at ~US$ 2 Bn in 2018 and is projected to expand at a CAGR of ~7% from 2019 to 2027. Biobanking Market: Overview Growth of the global biobanking market is attributed to an increase in the demand for biobanks in genomics and biomedical research, and rising focus on precision medicine. North America dominated the
Biobanking Market Overview and Regional Outlook Study
Biobanking Market Introduction The term 'biobanking' is often misused to refer to any collection of human biological specimens (biospecimens), regardless of the standards established for various tissue collection procedures or requirements pertaining to ethical and legal considerations. The process of collecting bodily fluids or tissue samples for usage in research to better understand health and disease is referred to as biobanking. Biobank is a sizable collection of biospecimens that are kept
Biobanking Market: Rising Impressive Business Opportunities Analysis Forecast by …
(Latest Industry Report 2022) Biobanking Market report provides a basic overview of the industry including definitions and classifications. The market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status. The study provides a complex examination of the application, including a detailed cost assessment analysis of the products available in the global market with respect to the profit margins of established manufacturers.
Biobanking Market Industry Trends, Estimation & Forecast, 2017 - 2025
Biobanking is a procedure to collect and preserve biological materials that can be further used for diagnosis, biodiversity studies, and research. The major factors that drive the growth of the global biobanking market include a rise in funding support by private & government organizations. Furthermore, increased incidence of chronic disease further propel the market growth. However, ethical and legal issues related to biobanking restrict market growth. The major factors for the